US approves Roche test for HIV and hepatitus

AFP
AFP - [email protected] • 9 Jan, 2015 Updated Fri 9 Jan 2015 15:01 CEST
image alt text

US authorities have approved a test developed by Swiss pharmaceutical firm Roche that can detect both HIV and hepatitis viruses, the Basel-based company said on Friday.

The Cobas Taqscreen MPX is the only test approved by the US Food and Drug Administration that can simultaneously detect the HIV, hepatitis B and C viruses in human blood and plasma, Roche said.
   
Having a single test eliminates "the need for consecutive rounds of testing" Roche said, stressing that it could shorten the time it takes to reach a crucial diagnosis of the killer viruses.
   
The human immunodeficiency virus (HIV) which causes AIDS, has killed some 39 million people since it emerged in the 1980s.
   
Hepatitis B and C, which are transmitted from infected mothers to newborn babies by unsafe injections during medical procedures and drug use, or unsafe sex, kill more than a million people each year.
   
Roche is a leader in the global blood and plasma screening market using so-called nucleic acid-based techniques, which allow earlier detection of virus or bacteria infections in antibody tests.
   
That market is worth an estimated 660 million euros ($779 million) worldwide.

More

Comments

AFP 2015/01/09 15:01

Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also